Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07824479

Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer

Sponsor: Ruijin Hospital

View on ClinicalTrials.gov

Summary

This study intends to employ FAPI and Grazytracer PET/CT to predict the therapeutic response to preoperative immunotherapy-based combination regimens in patients with advanced gastric cancer. The study is expected to provide an early, non-invasive predictive tool for immunotherapy-based combination therapy in gastric cancer, offer molecular imaging-based evidence for treatment stratification, and facilitate the optimization of precision therapeutic strategies.

Official title: Predicting Efficacy of Preoperative Immunotherapy Combined Treatment in Advanced Gastric Cancer

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2025-06-17

Completion Date

2033-05-31

Last Updated

2026-09-17

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

FAPI PET/CT Imaging

A FAP-targeted radiotracer for PET/CT imaging; administered intravenously.

DIAGNOSTIC_TEST

Grazytracer PET/CT Imaging

A Granzyme B-targeted radiotracer for PET/CT imaging; administered intravenously.

Locations (1)

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China